Successful Desensitization to Daratumumab After a Severe Life-threatening Reaction in a Patient With Refractory Multiple Myeloma
03 medical and health sciences
0302 clinical medicine
Antineoplastic Combined Chemotherapy Protocols
Antibodies, Monoclonal
Humans
Multiple Myeloma
DOI:
10.18176/jiaci.0678
Publication Date:
2021-02-04T17:18:51Z
AUTHORS (7)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....